Clinical Trial Detail

NCT ID NCT02500043
Title Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Trifluridine-tipiracil hydrochloride

Age Groups: adult

No variant requirements are available.